Search filters

Filters
Clear All

Phase

  • 59
  • 97
  • 108
  • 90
  • 14
  • 175
  • 704
  • 456
  • 14
  • 32
  • 1
  • 4
  • 655

Found 706 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Neurobiology of Caregiving in New Mothers (Children between 0-3 years old)
1 years - 42 years
Female
This study is to learn more about social processes on a behavioral and brain level in new mothers. If you are eligible, there are three in person visits, one consisting of an fMRI scan. MRI uses magnetic fields to take pictures of the brain. MRI does not use X-rays and …
18 years - 65 years
All genders
14.00 Normal 0 false false false EN-US X-NONE X-NONE We are looking for healthy volunteers to participate in a study to see if a particular type of medication (statin) has an impact on the kind of bacteria that are found in the gut, and if the gut bacteria affects how …
 Study to Evaluate the Safety and Efficacy of Upadacitinib in Giant Cell Arteritis: SELECT-GCA
50 years - 100 years
All genders
Phase 3
The main purpose of this study is to understand how well giant cell arteritis (also known as temporal arteritis; GCA) responds to an investigational drug called upadacitinib. Upadacitinib is being tested to find out if it is safe and effective in treating GCA. An investigational drug is one that is …
 A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at Risk of Progressing to End-Stage Renal Disease (NefIgArd)
1 years - 100 years
All genders
Phase 3
The research study is being conducted to see how well the investigational drug, Nefecon, works for the treatment of your kidney disease and more specific for patients with "primary immunoglobulin A nephropathy," called IgAN.
 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS-IgAN)
18 years - 80 years
All genders
Phase 3
This study will use a new investigational study drug called OMS721 in people with Immunoglobulin A (IgA) Nephropathy. This kidney disease produces abnormal amounts of a protein called IgA in the kidney that damage the filtering units or glomeruli. Glomeruli are tiny filtering units in the kidney that remove excess …
 The PATCH trial for Healthcare Workers (Prevention and Treatment of COVID-19 with hydroxychloroquine)
18 years - 95 years
All genders
The PATCH trial tests hydroxychloroquine as a treatment in patients with COVID-19 and a preventative medication in health care workers at high risk of contracting COVID-19. 
 The PATCH trial for patients Quarantined at Home (Prevention and Treatment of COVID-19 with hydroxychloroquine)
18 years - 95 years
All genders
A double-blind placebo controlled trial of high dose hydroxychloroquine (HCQ) as a treatment for COVID-19 positive patients who are quarantined at home
18 years - 85 years
All genders
Phase 1
Test Comment here..
 A Translational and Neurocomputational Evaluation of a D1R Partial Agonist for Schizophrenia
100 years or below
All genders
The purpose of this research is to test an experimental drug CVL-562 as a possible treatment for early-course schizophrenia, schizoaffective disorder or related psychotic disorder.This study will test whether CVL-562 can help thinking and memory in people with schizophrenia.
 EFFICACY AND SAFETY OF A ONCE-WEEKLY INJECTABLE MEDICINE IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY. (REDEFINE 1)
J
James David
18 years - 100 years
All genders
Phase 1
This study has 2 parts: The first part is the main study and the second part is the extension study. During the main study participants will receive 1 of 4 study medicines. If participants continue in the extension study, they will not receive any study medicine during the extension. The …